Avatrial
PrivateLast Round
Grant
Nov 29, 2024
Total Funding Raised
$95,000
Company Overview
Avatrial is a biotechnology company that offers integrated, end-to-end services for cancer drug discovery, using human tissue, multi-omic data generation, and machine learning for biomarker identification.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avatrial Comparables
Compare Avatrial with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Signet Therapeutics | 76% | |
| CELLphenomics GmbH | 76% | |
| Insitro | 74% |
Avatrial Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 29, 2024 | ||||
| Accelerator | Jul 2, 2024 |
Avatrial Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Quantum Computing Centre | Grant |
Recent news
Latest coverage and updates
- is_developingOct 20, 2026
Avatrial Ltd partners with Burjeel Holdings under an MoU to explore developing an integrated AI-powered cancer drug discovery ecosystem in United Arab Emirates that combines clinical data, molecular analysis, experimental research, multi-omics technologies, and patient-derived models to identify treatments and potentially advance them into clinical trials.
Avatrial Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Avatrial's valuation, stock price, and market status.
Is Avatrial a public or private company?
Avatrial is a private company.
What is the current stock price of Avatrial?
Avatrial is a private company, so its shares have no public market price. Caplight tracks Avatrial's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avatrial worth (valuation)?
Valuation information for Avatrial is not publicly available.
Can I buy Avatrial stock?
Avatrial shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avatrial's last funding round?
Avatrial's most recent funding round was Grant on November 29, 2024.
Who are the main investors in Avatrial?
Key investors in Avatrial include National Quantum Computing Centre.
Will Avatrial IPO soon?
No public IPO plans have been announced for Avatrial.
How can I track Avatrial secondary market activity?
Caplight tracks bids, offers, and trades in Avatrial's shares on secondary markets.